33rd International Vicenza Course on Critical Care Nephrology: Presentation Collection

Opening Ceremony

• Critical Care Nephrology from origin to today – C. Ronco
• Anecdotes in Critical Care Nephrology – J. Kellum

Session 1: Epidemiology of AKI 

• AKI Classification and the Conceptual Model of AKI – J. Kellum
• Epidemiology and Outcomes of AKI in Hospital and ICU – E. Hoste
• Incidence and Outcomes of AKI in Sepsis and MOF – R. Bellomo
• Incidence and Outcomes of AKI in Cardiac Surgery – N. Katz
• Risk Factors for AKI in Hospital and ICU – M. Rosner

Session 2: AKI – ICT and Economics, Debate on Renal Angina

• Electronic Records & Sniffers – K. Kashani
• The Health Economics of AKI – A. Lewington
• Renal Angina: New Concept, Perfect Term – L.S. Chawla

Session 3: RRT in AKI and Critical Illness

• Evolution of Technology in CRRT – C. Ronco
• Renal Remplacement Therapy: When to start in AKI – S. Bagshaw
• Clinical Indications and Patient Selection – R. Mehta
• Treatment Modality Selection – A. Tolwani
• How and why do filters clot? – R. Bellomo

Session 4: Multiple Organ Support Therapies

• Extracorporeal Ultrafiltration for Heart Failure – C. Ronco
• Extracorporeal CO2 Removal – C. Ronco
• Extracorporeal Liver Support – J.A. Wendon
• CRRT and ECMO – A. Shaw

Session 5: Biomarkers of AKI

• AKI Biomarkers: Which One? How to Use Them? – M. Haase
• Does Renal Functional Reserve Exist in ICU Patients? – R. Bellomo
• Biomarkers and AKI Prevention – J. Kellum
• Biomarker-Driven Change in AKI Therapy – N. Gibney

Session 6: AKI – Pathophysiology, Prevention, Recovery, Progression

• Septic Kidney Injury: Update on Pathophysiology – B. Molitoris
• Prevention of AKI: What Evidence? – M. Joannidis
• Pathways of Renal Recovery or Progression after AKI – R. Mehta
• Modality of Artificial Renal Support and Renal Recovery – R. Bellom
• Ischemic Preconditioning – J. Kellum

Session 7: CardioRenal Crosstalk 

• AKI after Acute Myocardial Infarction: Contrast, Organ Crosstalk and Complications – P. McCullough
• Importance of Congestion and Diastolic Dysfunction – M. S?emann
• Uric Acid as a risk factor for heart and kidney therapeutic management – C. Ronco
• Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights into Prevention and Clinical Management – P. McCullough
• New Therapeutic Strategy of Aquaresis for Cardiorenal Syndrome – K. Doi

Session 8: Fluid management

• Fluid Assessment, Outcomes and Strategies in the Critically Ill – R. Mehta
• Balanced Fluid or Saline? – R. Bellomo
• Use of Diuretics in the Critically Ill and CRS – L.S. Chawla
• Indications to Medical Fluid Removal in HF and Fluid Overload – M. Ostermann

Session 9: Critical Care Nephrology Issues

• A case study using Lectin-Affinity Plasmapheresis in the Treatment of Ebola Virus Disease – R. Kenley
• AKI in Trauma: Rhabdomyolysis & Burms – F. Mariano
• Sorbent Therapy and Endotoxin Removal – C. Ronco
• Renal Outcomes after Cardiac Surgery – A. Shaw
• High Cut Off Membranes – G. Villa
• Citrate vs Heparin vs No Anticoagulation – P. Honor?
• RRT in Critically Ill Children and Neonates – S. Goldstein

Session 10: New Horizons in AKI and CRRT

• Hypothermia & the Kidney – S. De Rosa
• Nomenclature for RRT in AKI – J. Cerda
• From the Italian Survey: the IRRIV Score – J. Zaragoza
• Metabolic Alkalosis in the ICU – M. Emmett